Summary
This 8-K filing from CVS Health Corporation (CVS) announces a significant strategic acquisition. On April 4, 2004, CVS entered into an Asset Purchase Agreement to acquire approximately 1,260 Eckerd drugstores, primarily located in the southern United States, along with Eckerd's mail order, specialty pharmacy, and pharmacy benefit management (PBM) businesses. This acquisition, valued at $2.15 billion subject to working capital adjustments, represents a substantial expansion of CVS's retail footprint and its PBM operations. The transaction is structured as an asset purchase for the drugstores and a stock purchase for the PBM business. Notably, the deal is contingent on customary closing conditions, including regulatory approval under the Hart-Scott-Rodino Act, and is cross-conditioned on the simultaneous sale of the remaining Eckerd business (primarily northern and mid-Atlantic drugstores) by J.C. Penney to The Jean Coutu Group (PJC) Inc. This move signals a significant shift in the drugstore landscape and demonstrates CVS's aggressive growth strategy.
Key Highlights
- 1CVS is acquiring approximately 1,260 Eckerd drugstores and associated pharmacy businesses (mail order, specialty, PBM) for $2.15 billion.
- 2The acquisition primarily targets Eckerd stores in the southern United States, including key markets like Texas and Florida.
- 3The deal involves both an asset purchase for the retail drugstores and a stock purchase for the pharmacy benefit management (PBM) business.
- 4The transaction is subject to standard closing conditions, including Hart-Scott-Rodino Act regulatory approval.
- 5The acquisition is cross-conditioned on J.C. Penney's sale of the remaining Eckerd business to The Jean Coutu Group (PJC) Inc., with provisions for financing contingencies.
- 6This acquisition is a major strategic move to expand CVS's retail presence and enhance its PBM capabilities.
- 7The filing includes the Asset Purchase Agreement and a press release dated April 5, 2004, as exhibits.